UBS (Irl) Fund Solutions plc MSCI USA Value UCITS ETF (USD) A-dis (UC07)
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
8,400.00p
8,383.62p
9,454.50p
London
8,400.00p
8,383.62p
7,683.00p
$479.07M
1.50p (0.02%) Previous:
1.50p
1
n/a
GBX
ETP Basics
| Issuer: | UBS Asset Management |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Full Replication |
| Securities lending: | No |
| Number of holdings: | 452 |
| Size: | $479.1M |
| Launch date: | 11 April 2012 |
| Launch price: | $42.24 |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00B78JSG98 |
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website for more information.
Annual & interim reports
Before you invest, please make sure you read the documents below
What is a Value Assessment?
Fund Managers are required to regularly assess whether the fund they manage delivers value to investors. When completing their assessment, they will consider investment performance, service offered, costs and charges, and competitor funds. The Assessment of Value for funds is subject to the Financial Conduct Authority's Collective Investment Scheme (COLL) rules or a Price and Value Assessment (PRIN) for other funds not subject to COLL rules.
Why it matters to investors?
The Value Assessment helps an investor understand how a Fund Manager has considered how their fund has delivered value for money or is expected to deliver value for money. The Fund Manager will explain the actions they are taking if their fund has not delivered value for money or it is not expected to deliver value for money.
Value Assessment
| Value Assessment review date: | 26 July 2024 |
|---|---|
| Value Assessment next review date: | 31 July 2025 |
| Is Assessment of Value required under COLL: | No |
| Outcome of COLL Assessment of Value: | n/a |
| Outcome of PRIN Value Assessment or review: | - |
| Other review related to value and or charges: | Fund costs have been reviewed and are in line with ESMA's briefing on supervision of costs in UCITS and AIFs or relevant NCA supervisory activity |
| Further information: | - |
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | MSCI USA Value Total Return Net |
|---|---|
| Aim: |
The UBS (Irl) ETF plc – MSCI USA Value UCITS ETF sub-fund is an exchange traded fund...
Read full aim for UBS (Irl) Fund Solutions plc |
| Leverage: | 100% |
| Currency hedging: | No |
COSTS
| Ongoing Charge (OCF/TER): | 0.20% |
|---|---|
| Management fee: | 0.20% |
| Indicative spread: | 0.11% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
| 1 week 1W | 0.42% | 1 year 1Y | 1.61% |
|---|---|---|---|
| 1 month 1M | 1% | 2 years 2Y | 14.4% |
| 3 months 3M | 1.95% | 3 years 3Y | 19.73% |
| 6 months 6M | 7.03% | 5 years 5Y | 47.42% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
| Security | Weight |
|---|---|
| BERKSHIRE HATHAWAY | 3.01% |
| JPMORGAN CHASE & CO | 2.92% |
| EXXON MOBIL CORPORATION | 1.97% |
| PROCTER & GAMBLE COMPANY(THE) | 1.62% |
| UNITEDHEALTH GROUP INCORPORATED | 1.60% |
| JOHNSON & JOHNSON | 1.59% |
| THE HOME DEPOT | 1.52% |
| ABBVIE | 1.46% |
| COCA-COLA COMPANY(THE) | 1.25% |
| BANK OF AMERICA CORP | 1.15% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.